Either a lot of these funds started fundraising before the crisis, are buddy-buddy with the LPs, or both, because yet another VC has raised a sizeable chunk of cash.

Today, 5AM Ventures announced that it raised $119.25M, inching towards the fund’s $150M goal. The money came from undisclosed private investors, endowments, foundations and pensions.

This is the third fund for 5AM, behind its first fund of $65M in 2002 and $150M in 2006.

5AM has a pretty good track record, which is probably why investors laid down $120M more green. Here’s a list of the firm’s exits:

1. Panomics – sold to Affymetrix for $73M

2. Ilypsa- sold to Amgen for $420M

3. Milkana Therapeutics – sold to EntreMed for $21M in stock

4. Alexza – IPO 2006

Recent investments include Anaphore, Pearl Therapeutics and Synosia Therapeutics.

Image from 5AM Ventures

Related Posts